Agree George.
This is great news fo us shareholders, but seems to be a material announcement.
Has anybody got more comments on the timing or scope of this stage 2?
Janssen elected to expand the collaboration in March 2020 ▪ Stage 2 study to determine if PromarkerD can help assess the effectiveness of canagliflozin as a treatment for diabetic kidney disease
PIQ Price at posting:
45.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)